戻る Agenda
Opening Plenary and Keynote Address: From Personal Journeys to Global Solutions – Collaborating for Innovation and Patient Impact
Session Chair(s)
Maria Vassileva, PhD
Chief Science and Regulatory Officer
DIA, United States
Start your day with a powerful and inspiring session that brings together visionary leaders, groundbreaking science, and real-world patient experiences. DIA President and CEO Marwan Fathallah sets the stage, followed by a moving personal story from Jimi Olaghere, who shares his extraordinary journey from a sickle cell diagnosis to conquering Mt. Kilimanjaro. Dive into the future of innovative treatments with a keynote on Type 1 Diabetes breakthroughs by renowned researcher Douglas Melton. The session concludes with a dynamic multi-stakeholder panel, where top regulators, researchers, and industry leaders explore how global collaboration can accelerate patient-centered innovation and derisk product development.
Learning Objective : Describe how patient experiences and personal journeys can inform and inspire innovative approaches to drug development and healthcare solutions; Analyze the scientific and regulatory challenges associated with developing innovative treatments for chronic and rare diseases, such as Type 1 Diabetes and Sickle Cell Anemia; Identify collaborative strategies that enable multi-stakeholder partnerships to derisk medical product development and accelerate patient access to innovative therapies.
Speaker(s)
Moderator
Maria Vassileva, PhD
DIA, United States
Chief Science and Regulatory Officer
Panelist
Emer Cooke, MBA, MSc
European Medicines Agency, Netherlands
Chair, ICMRA; Executive Director
Panelist
Marty Makary, MD, MPH
FDA, United States
Commissioner
The Future of Innovative Treatments
Doug Melton, PhD
Vertex, United States
Distinguished Research Fellow
From Sickle Cell to the Summit: My Journey to the Top of Kilimanjaro
Jimi Olaghere
Principal at Sugarloaf Capital, United States
Patient Advocate
Panelist
Sudip Parikh, PhD
American Association for the Advancement of Science (AAAS), United States
Chief Executive Officer and Executive Publisher, Science Journals
Panelist
Lawrence Tallon
Medicines and Healthcare products Regulatory Agency, United Kingdom
Chief Executive Officer